Conference
Abstract 5289: The role of the immune system in lymph node positive ER+ breast cancer
Abstract
Abstract
Estrogen receptor (ER) positive breast cancer (BC) accounts for 70% of BC diagnoses and is associated with a good outcome when treated with conventional therapies, including tamoxifen. However, there remains a sub-population of patients who undergo relapse within 10 years of diagnosis and do not respond well to standard therapies. While lymph node (LN) status is an important indicator of poor prognosis, additional …
Authors
Cockburn JG; Gillgrass A; Bane A
Volume
75
Pagination
pp. 5289-5289
Publisher
American Association for Cancer Research (AACR)
Publication Date
August 1, 2015
DOI
10.1158/1538-7445.am2015-5289
Conference proceedings
Cancer Research
Issue
15_Supplement
ISSN
0008-5472